Bleichroeder LP’s Filana Therapeutics FLNA Stock Holding History

Bleichroeder LP’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,000	Closed	-$209K	–	89
2022 Q3	$209K	Hold	5,000	–	–	0.04%	52
2022 Q2	$141K	Hold	5,000	–	–	0.03%	62
2022 Q1	$186K	Sell	5,000 -7,500	-60%	-$318K	0.03%	79
2021 Q4	$546K	Buy	+12,500	New	+$655K	0.09%	64
2021 Q3	–	Sell	-375,000	Closed	-$32M	–	101
2021 Q2	$32M	Sell	375,000 -125,000	-25%	-$6.7M	4.83%	7
2021 Q1	$22.5M	Buy	500,000 +215,686	+76%	+$8.48M	3.79%	8
2020 Q4	$1.94M	Sell	284,314 -400,189	-58%	-$3.57M	0.38%	33
2020 Q3	$7.88M	Sell	684,503 -366,000	-35%	-$1.65M	1.41%	19
2020 Q2	$3.24M	Sell	1,050,503 -689,037	-40%	-$3.13M	0.57%	30
2020 Q1	$7.15M	Hold	1,739,540	–	–	1.87%	16
2019 Q4	$9.05M	Buy	+1,739,540	New	+$3M	1.43%	18

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bleichroeder LP's FLNA Position: Q4 2022 in Review

Bleichroeder LP sold out of Filana Therapeutics (FLNA) in Q4 2022, closing a stake of 5,000 shares — an estimated $209K sold.

Bleichroeder LP first reported a position in FLNA in Q4 2019 and held it in 11 quarters. The position peaked at $32M in Q2 2021. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2022.

Bleichroeder LP reported no remaining Filana Therapeutics position as of Q4 2022 after selling out during the quarter.
Bleichroeder LP sold 5,000 Filana Therapeutics shares in Q4 2022, an estimated $209K.
Bleichroeder LP first reported a position in Filana Therapeutics in Q4 2019 and held it in 11 quarters.
Bleichroeder LP's Filana Therapeutics position peaked at $32M in Q2 2021.
153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2022.

Based on Bleichroeder LP's 13F filing for Q4 2022, filed 14 Feb 2023.